SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors anticipate a major catalyst from the final survival events of its Phase 3 REGAL trial for GPS, while the stock faces significant volatility driven by a massive short squeeze. The community is intensely debating whether this momentum will trigger a potential buyout, with bulls pointing to revolutionary clinical data and shorts facing severe margin pressure due to extremely high borrow costs.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending due to heightened volatility as global markets react to a 60-day roadmap toward a peace deal between the U.S. and Iran, including the temporary suspension of sanctions on Iranian oil exports. Community members are intensely debating whether this signals a long-term supply normalization that will push prices lower or if the ongoing geopolitical instability makes this a temporary relief rally.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to a recent negative opinion from the EMA, which has prompted plans for an appeal and re-examination through an independent expert panel. Community discussion is focused on the potential for a regulatory reversal, the significance of the upcoming US J-code implementation for Yartemlea, and frustration regarding recent executive departures and the company's communication strategy.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals is experiencing significant market interest following a strong quarterly earnings report that beat profit expectations, driven by the continued growth of its Dupixent and Eylea HD franchises. Community discussions highlight optimism regarding its robust drug pipeline and potential future regulatory milestones, even as some investors remain focused on how the company will navigate competitive pressures and address ongoing manufacturing site updates.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community speculation, with traders debating whether the asset is primed for a massive short squeeze or trapped in a persistent pump-and-dump cycle. The discourse is fueled by aggressive retail buying, ongoing comparisons to previous price spikes, and persistent allegations of market manipulation.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as investors track the development of its Helios data center campus and await news on a major tenant, with community discourse centered on whether management can capitalize on institutional interest in AI and crypto infrastructure. Technical analysis is a focal point, with many traders closely monitoring a key resistance level near $35 while debating if the stock's recent performance is lagging behind other high-beta data center and compute-linked peers.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund ($XLE) is currently experiencing high volatility driven by deep uncertainty surrounding the Strait of Hormuz, as market participants debate whether recent de-escalation headlines signal a true energy supply reset or merely temporary geopolitical maneuvering. Community sentiment remains polarized, with traders actively debating the structural impact of record-low inventories and shifting trade routes against the persistent threat of further regional escalation.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending due to reports that it is exploring the sale of its DePuy Synthes orthopedics unit, a move valued at over $20 billion that would allow the healthcare giant to reallocate capital toward higher-growth pharmaceutical and med-tech segments. Investors are actively discussing this strategic pivot as a potential catalyst for valuation compression, while the community monitors the firm's broader efforts to expand its oncology pipeline and maintain dividend stability.

TOSHI

TOSHI is trending as community members closely monitor rumors of an AI-utility pivot and ecosystem expansion, fueling optimism for a structural breakout despite recent consolidation. Supporters are actively discussing a supply-reducing 'buyback and lock' mechanism and anticipate that increased integration within the Base network will drive future momentum.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is experiencing significant volatility as investors weigh the potential impact of new stablecoin competition against long-term growth prospects tied to the Clarity Act and the expansion of the agentic AI payment economy. The community remains deeply divided, with many retail investors expressing frustration over recent price declines while others view the current dip as a strategic accumulation opportunity ahead of anticipated regulatory and product milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

6 Factors to Play Europe ETFs Now

Europe Investing Gains Wall Street Favor: Time to Jump Into ETFs?

First Trust Exchange-Traded AlphaDEX Fund II - First Trust Europe AlphaDEX Fund

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

FEPFirst Trust Exchange-Traded Fund III - First Trust Europe AlphaDEX Fund

Latest FEP News